ROS1 and central nervous system cancer: In 2019, the first international joint study focusing on fusion genes of infantile gliomas reported that almost all ROS1 or NTRK fusion genes were found in hemispheric primary tumors, and over 80% of these genes were found in malignant tumors [66].